NICE endorses use of digital therapies for psychosis

pharmaphorum

Author: Phil Taylor.  Published: 25 March 2024

Three digital health technologies (DHTs) used to support patients with psychosis can be used by the NHS while additional evidence of their benefits is gathered.

The recommendation comes in an early value assessment (EVA) from health technology assessment (HTA) agency NICE and covers the DHTs AVATAR Therapy to manage verbal hallucinations (hearing voices), SlowMo for managing distressing thoughts or paranoia, and CareLoop for relapse prevention.
The EVA means that the developers of the DHTs can make them available to NHS care teams, provided they commit to gathering evidence on them for three years and providing NICE with an annual update on that process.

Read more …